Overrunning and underrunning in sequential clinical trials
- 1 April 1992
- journal article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 13 (2) , 106-121
- https://doi.org/10.1016/0197-2456(92)90017-t
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Letter to the editorControlled Clinical Trials, 1991
- Comparison of Bayesian with group sequential methods for monitoring clinical trialsControlled Clinical Trials, 1989
- Why do we need systematic overviews of randomized trials? (Transcript of an oral presentation, modified by the editors)Statistics in Medicine, 1987
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trialBritish Journal of Cancer, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983
- The analysis of a sequential clinical trial for the comparison of two lung cancer treatmentsStatistics in Medicine, 1983
- The design of a sequential clinical trial for the comparison of two lung cancer treatmentsStatistics in Medicine, 1982
- Group sequential methods in the design and analysis of clinical trialsBiometrika, 1977